急性髓系白血病中模拟急性早幼粒细胞白血病的新NUP98-JADE2融合
本文报告一例呈现APL样形态和免疫表型的儿童AML患者中鉴定出的NUP98-JADE2融合。机制上,NUP98-JADE2可损害全反式维甲酸(ATRA)介导的转录调控和髓系分化,并改变野生型JADE2的亚细胞分布。这是首次在模拟APL的AML患者中报道NUP98-非RAR重排,提示JADE2破坏导致的维甲酸信号改变可能解释APL样特征。
要点
- 在模拟APL的儿童AML中首次鉴定出NUP98-JADE2融合。
- NUP98-JADE2损害ATRA介导的转录调控和髓系分化。
- JADE2下调同样减弱ATRA诱导的反应和髓系活化。
核心结论
- NUP98-JADE2融合可能通过抑制JADE2介导的维甲酸信号改变导致APL样特征。
研究设计与样本
- 本文为病例报告及功能 characterization,对象为一例呈现APL样形态和免疫表型的儿童AML患者。
主要发现
- NUP98-JADE2可损害ATRA介导的转录控制和髓系分化。
- NUP98-JADE2改变野生型JADE2的亚细胞分布。
- JADE2下调同样导致ATRA诱导反应和髓系活化减弱。
临床怎么用
- 对形态和免疫表型模拟APL但缺乏RARA重排的AML患者,可考虑检测NUP98-JADE2等非RAR重排。
局限性
- 本文为单例病例报告,机制结论主要基于该病例的体外实验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute promyelocytic leukemia (APL) is a specific subtype of acute myeloid leukemia (AML) characterized by block of differentiation at the promyelocytic stage and the presence of PML-RARA fusion. In rare instances, RARA is fused with other partners in variant APL. More infrequently, non-RARA genes are rearranged in AML patients resembling APL. However, the underlying disease pathogenesis in these atypical cases is largely unknown. Here, we report the identification and characterization of a NUP98- JADE2 fusion in a pediatric AML patient showing APL-like morphology and immunophenotype. Mechanistically, we showed that NUP98-JADE2 could impair all-trans retinoic acid (ATRA)-mediated transcriptional control and myeloid differentiation. Intriguingly, NUP98-JADE2 was found to alter the subcellular distribution of wild-type JADE2, whose down-regulation similarly led to attenuated ATRA-induced responses and myeloid activation, suggesting that NUP98-JADE2 may mediate JADE2 inhibition. To our knowledge, this is the first report of a NUP98-non-RAR rearrangement identified in an AML patient mimicking APL. Our findings suggest JADE2 as a novel myeloid player involved in retinoic acid-induced differentiation. Despite lacking a rearranged RARA, our findings implicate that altered retinoic acid signaling by JADE2 disruption may underlie the APL-like features in our case, corroborating the importance of this signaling in APL pathogenesis.
引用
- Cheng CK, Chan HY, Yung YL, et al. A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia. Blood Adv. 2022. PMID: 34673934. doi:10.1182/bloodadvances.2021006064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。